{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:45:53Z","timestamp":1768441553834,"version":"3.49.0"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ebm-journal.org"],"crossmark-restriction":true},"short-container-title":["Exp. Biol. Med."],"abstract":"<jats:p>\n                    Even with the development of the Pfizer-BioNTech BNT162b2 vaccine, which provides protection against COVID-19 and demonstrates high efficacy in generating immune responses, the complexities of the dynamics linking pro- and anti-inflammatory cytokine profiles with anti-spike IgG production remain unclear. The study aims to elucidate these immune dynamics after vaccination. This prospective cohort research was done at the University of Diyala from January 2022 to January 2023, evaluating the immunological response to the Pfizer-BNT162b2 mRNA vaccine in 180 healthy students. Pro- and anti-inflammatory cytokines and anti-spike IgG antibodies were measured before vaccination, 1\u00a0month after the second dose, and 4\u00a0months after the second dose. Biomarkers were analyzed via ELISA and CRP assays. The study involved 180 healthy participants (80 males, 100 females; median age, 21 years; BMI, 25.7\u00a0kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ). After the first Pfizer-BNT162b2 vaccine dose, the level of anti-spike IgG increased by 330-fold, and the levels of pro- and anti-inflammatory markers, such as IL-1\u03b2, IL-10, and CRP, increased significantly. Four months after the second dose, anti-spike IgG levels were 136-fold above baseline. Significant correlations emerged between cytokine and IgG levels, with anti-spike IgG\/IL-10 ratios elevated and sustained over the long term. Pfizer-BNT162b2 vaccine elicits a significant immune response associated with changes in pro-inflammatory cytokines, and the interaction between these cytokines and anti-spike IgG suggests a potential role for immune regulation in enhancing humoral immunity. Based on these findings, the IgG\/IL-17 ratio may serve as a viable exploratory biomarker for assessing short- and medium-term vaccination efficacy.\n                  <\/jats:p>","DOI":"10.3389\/ebm.2025.10849","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:15:58Z","timestamp":1768403758000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The correlation between pro- and anti-inflammatory cytokines and anti-spike IgG antibody responses induced by the SARS-CoV-2 coronavirus vaccine"],"prefix":"10.3389","volume":"250","author":[{"given":"Mustafa Abdulkareem","family":"Salman","sequence":"first","affiliation":[{"name":"Department of Biology, Graduate School of Natural and Applied Science, Erciyes University","place":["Kayseri, T\u00fcrkiye"]},{"name":"Department of Anatomy, College of Medicine, University of Diyala","place":["Diyala, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thowiba Yousif","family":"Jameel","sequence":"additional","affiliation":[{"name":"Department of Biology, Graduate School of Natural and Applied Science, Erciyes University","place":["Kayseri, T\u00fcrkiye"]},{"name":"Department of Biology, Faculty of Science, Tikrit University","place":["Tikrit, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdurrahman","family":"Ayvaz","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Science, Erciyes University","place":["Kayseri, T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Rushdi","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Head of the Microbiology Department, Medical College, Aliraqia University","place":["Baghdad, Iraq"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ophtha.2022.08.027","article-title":"Vaccine-associated Uveitis after COVID-19 vaccination: Vaccine adverse event reporting system database analysis","volume":"130","author":"Singh","year":"2023","journal-title":"Ophthalmology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/vaccines9070734","article-title":"Detailed dissection and critical evaluation of the Pfizer\/BioNTech and moderna mRNA vaccines","volume":"9","author":"Xia","year":"2021","journal-title":"Vaccines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1038\/s41467-024-51411-9","article-title":"Innate immune responses against mRNA vaccine promote cellular immunity through IFN-\u03b2 at the injection site","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1292568","DOI":"10.3389\/fimmu.2023.1292568","article-title":"Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations","volume":"14","author":"Rosati","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1016\/S2666-5247(23)00171-4","article-title":"Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study","volume":"4","author":"Zhu","year":"2023","journal-title":"The Lancet Microbe"},{"key":"B6","doi-asserted-by":"publisher","first-page":"109504","DOI":"10.1016\/j.celrep.2021.109504","article-title":"Systemic IL-15, IFN-\u03b3, and IP-10\/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients","volume":"36","author":"Bergamaschi","year":"2021","journal-title":"Cell Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e00148","DOI":"10.1002\/adtp.202500148","article-title":"Cytokine mRNA delivery and local immunomodulation in the placenta using lipid nanoparticles","volume":"8","author":"Hofbauer","year":"2025","journal-title":"Adv Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41591-022-01739-w","article-title":"Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial","volume":"28","author":"Chu","year":"2022","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"eabj9853","DOI":"10.1126\/science.abj9853","article-title":"Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells","volume":"374","author":"Mateus","year":"2021","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.12938","article-title":"The role of transforming growth factor \u03b2 in T helper 17 differentiation","volume":"155","author":"Zhang","year":"2018","journal-title":"Immunology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.32007\/jfacmedbagdad.2039","article-title":"Effect of Covid-19 vaccine on some immunological salivary biomarkers (sIgA and Interleukine-17)","volume":"65","author":"Ali","year":"2023","journal-title":"J Fac Med Baghdad"},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4167\/jbv.2021.51.3.089","article-title":"Roles of interleukin-17 and th17 responses in COVID-19","volume":"51","author":"Kang","year":"2021","journal-title":"J Bacteriol Virol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"734279","DOI":"10.3389\/fimmu.2021.734279","article-title":"Interleukin-1 inhibitors and vaccination including COVID-19 in inflammatory rheumatic diseases: a nonsystematic review","volume":"12","author":"Atag\u00fcnd\u00fcz","year":"2022","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"152304","DOI":"10.1016\/j.imbio.2022.152304","article-title":"CD4 and IL-2 mediated NK cell responses after COVID-19 infection and mRNA vaccination in adults","volume":"228","author":"Alhajjat","year":"2023","journal-title":"Immunobiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/vaccines12070790","article-title":"Clinical and diagnostic features of post-acute COVID-19 vaccination syndrome (PACVS)","volume":"12","author":"Mundorf","year":"2024","journal-title":"Vaccines"},{"key":"B18","doi-asserted-by":"publisher","first-page":"922422","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"920627","DOI":"10.3389\/fimmu.2022.920627","article-title":"Immunologic phenotype of patients with long-COVID syndrome of 1-year duration","volume":"13","author":"Garc\u00eda-Abell\u00e1n","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.22092\/ARI.2022.359934.2517","article-title":"Increasing levels of serum anti-spike S1-RBD IgG after 120 days of the Pfizer-BioNTech-mRNA second dose vaccination","volume":"78","author":"Abdul-Wahab","year":"2023","journal-title":"Arch Razi Inst"},{"key":"B21","doi-asserted-by":"publisher","first-page":"602130","DOI":"10.3389\/fimmu.2021.602130","article-title":"Lung protection vs. infection resolution: interleukin 10 suspected of double-dealing in COVID-19","volume":"12","author":"Lindner","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.anai.2023.03.009","article-title":"The role of interleukin 13 and the type 2 immune pathway in COVID-19: a review","volume":"130","author":"Sasson","year":"2023","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Experimental Biology and Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10849\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:15:59Z","timestamp":1768403759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ebm-journal.org\/articles\/10.3389\/ebm.2025.10849\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":22,"alternative-id":["10.3389\/ebm.2025.10849"],"URL":"https:\/\/doi.org\/10.3389\/ebm.2025.10849","relation":{},"ISSN":["1535-3699"],"issn-type":[{"value":"1535-3699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"10849"}}